<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh17168-bib-0004">
 <label>4</label>
 <mixed-citation publication-type="journal" id="bjh17168-cit-0004">
  <string-name>
   <surname>Fox</surname>
   <given-names>TA</given-names>
  </string-name>, 
  <string-name>
   <surname>Troy‐Barnes</surname>
   <given-names>E</given-names>
  </string-name>, 
  <string-name>
   <surname>Kirkwood</surname>
   <given-names>AA</given-names>
  </string-name>, 
  <string-name>
   <surname>Chan</surname>
   <given-names>WY</given-names>
  </string-name>, 
  <string-name>
   <surname>Day</surname>
   <given-names>JW</given-names>
  </string-name>, 
  <string-name>
   <surname>Chavda</surname>
   <given-names>SJ</given-names>
  </string-name>, et al. 
  <article-title>Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy</article-title>. 
  <source xml:lang="en">Br J Haematol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1111/bjh.17027</pub-id>.
 </mixed-citation>
</ref>
